Ilumya Injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Ilumya Injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Ilumya
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ilumya Injection-Insulin degludec
- Ilumya Injection-Insulin Degludec (U-100) Prefilled Pens
- Ilumya Injection-Insulin Degludec (U-100) Vials
- Ilumya Injection-Insulin Degludec (U-200) Prefilled Pens
- Ilumya Injection-Insulin degludec and liraglutide
- Ilumya Injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Iluvien
- Insulin aspart, recombinant Subcutaneous-Iluvien Implant
- Insulin aspart, recombinant Subcutaneous-Imatinib
- Insulin aspart, recombinant Subcutaneous-Imatinib Mesylate
- Insulin aspart, recombinant Subcutaneous-Imbruvica
- Insulin aspart, recombinant Subcutaneous-Imbruvica (Ibrutinib Capsules)